The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine
Abstract Pancreatic cancer is one of the most lethal and chemo-resistant cancers worldwide. Growing evidence supports the theory that the gut microbiota plays an essential role in modulating the host response to anti-cancer therapy. The present study aimed to explore the effect of probiotics as an a...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15cf03039bce4227a77ea1f341924212 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:15cf03039bce4227a77ea1f341924212 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:15cf03039bce4227a77ea1f3419242122021-12-02T15:09:23ZThe synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine10.1038/s41598-020-77322-52045-2322https://doaj.org/article/15cf03039bce4227a77ea1f3419242122020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77322-5https://doaj.org/toc/2045-2322Abstract Pancreatic cancer is one of the most lethal and chemo-resistant cancers worldwide. Growing evidence supports the theory that the gut microbiota plays an essential role in modulating the host response to anti-cancer therapy. The present study aimed to explore the effect of probiotics as an adjuvant during chemotherapy for pancreatic cancer. An LSL-Kras G12D/− -Pdx-1-Cre mouse model of pancreatic ductal adenocarcinoma (PDAC) was created to study the effects of using four-week multi-strain probiotics (Lactobacillus paracasei GMNL-133 and Lactobacillus reuteri GMNL-89) as an adjuvant therapy for controlling cancer progression. At 12 weeks of age, pancreatitis was induced in the mice by two intraperitoneal injection with caerulein (25 μg/kg 2 days apart). Over the next 4 weeks the mice were treated with intraperitoneal injections of gemcitabine in combination with the oral administration of probiotics. The pancreas was then harvested for analysis. Following caerulein treatment, the pancreases of the LSL-Kras G12D/− -Pdx-1-Cre transgenic mice exhibited more extensive pancreatic intraepithelial neoplasia (PanIN) formation. Combined treatment with gemcitabine and probiotics revealed a lower grade of PanIN formation and a decrease in the expression of vimentin and Ki-67. Mice that received gemcitabine in combination with probiotics had lower aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. Notably, the use of high-dose probiotics alone without gemcitabine also had an inhibitory effect on PanIN changes and serum liver enzyme elevation. These findings suggest that probiotics are able to make standard chemotherapy more effective and could help improve the patient’s tolerance of chemotherapy.Shan-Ming ChenWee-Wei ChiengSzu-Wei HuangLi-Jin HsuMing-Shiou JanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-12 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shan-Ming Chen Wee-Wei Chieng Szu-Wei Huang Li-Jin Hsu Ming-Shiou Jan The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
description |
Abstract Pancreatic cancer is one of the most lethal and chemo-resistant cancers worldwide. Growing evidence supports the theory that the gut microbiota plays an essential role in modulating the host response to anti-cancer therapy. The present study aimed to explore the effect of probiotics as an adjuvant during chemotherapy for pancreatic cancer. An LSL-Kras G12D/− -Pdx-1-Cre mouse model of pancreatic ductal adenocarcinoma (PDAC) was created to study the effects of using four-week multi-strain probiotics (Lactobacillus paracasei GMNL-133 and Lactobacillus reuteri GMNL-89) as an adjuvant therapy for controlling cancer progression. At 12 weeks of age, pancreatitis was induced in the mice by two intraperitoneal injection with caerulein (25 μg/kg 2 days apart). Over the next 4 weeks the mice were treated with intraperitoneal injections of gemcitabine in combination with the oral administration of probiotics. The pancreas was then harvested for analysis. Following caerulein treatment, the pancreases of the LSL-Kras G12D/− -Pdx-1-Cre transgenic mice exhibited more extensive pancreatic intraepithelial neoplasia (PanIN) formation. Combined treatment with gemcitabine and probiotics revealed a lower grade of PanIN formation and a decrease in the expression of vimentin and Ki-67. Mice that received gemcitabine in combination with probiotics had lower aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. Notably, the use of high-dose probiotics alone without gemcitabine also had an inhibitory effect on PanIN changes and serum liver enzyme elevation. These findings suggest that probiotics are able to make standard chemotherapy more effective and could help improve the patient’s tolerance of chemotherapy. |
format |
article |
author |
Shan-Ming Chen Wee-Wei Chieng Szu-Wei Huang Li-Jin Hsu Ming-Shiou Jan |
author_facet |
Shan-Ming Chen Wee-Wei Chieng Szu-Wei Huang Li-Jin Hsu Ming-Shiou Jan |
author_sort |
Shan-Ming Chen |
title |
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
title_short |
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
title_full |
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
title_fullStr |
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
title_full_unstemmed |
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
title_sort |
synergistic tumor growth-inhibitory effect of probiotic lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/15cf03039bce4227a77ea1f341924212 |
work_keys_str_mv |
AT shanmingchen thesynergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT weeweichieng thesynergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT szuweihuang thesynergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT lijinhsu thesynergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT mingshioujan thesynergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT shanmingchen synergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT weeweichieng synergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT szuweihuang synergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT lijinhsu synergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine AT mingshioujan synergistictumorgrowthinhibitoryeffectofprobioticlactobacillusontransgenicmousemodelofpancreaticcancertreatedwithgemcitabine |
_version_ |
1718387798172499968 |